125 related articles for article (PubMed ID: 3276827)
1. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE
J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827
[TBL] [Abstract][Full Text] [Related]
2. The epipodophyllotoxin teniposide in therapy for childhood acute lymphocytic leukemia.
Rivera GK
J Clin Oncol; 1988 Feb; 6(2):191-3. PubMed ID: 3276820
[No Abstract] [Full Text] [Related]
3. Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia.
Hoelzer D; Thiel E; Löffler H; Büchner T; Ganser A; Heil G; Kurrle E; Heimpel H; Koch P; Lipp T
Semin Oncol; 1987 Jun; 14(2 Suppl 1):92-7. PubMed ID: 3473688
[No Abstract] [Full Text] [Related]
4. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C
Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782
[No Abstract] [Full Text] [Related]
5. Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia.
Sanz GF; Sanz MA; Rafecas FJ; Martínez JA; Martín-Aragonés G; Marty ML
Cancer Treat Rep; 1986 Nov; 70(11):1321-3. PubMed ID: 3464352
[TBL] [Abstract][Full Text] [Related]
6. Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.
Linker CA; Levitt LJ; O'Donnell M; Ries CA; Forman SJ
Semin Oncol; 1987 Jun; 14(2 Suppl 1):78-85. PubMed ID: 3473686
[No Abstract] [Full Text] [Related]
7. Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
Rivera G; Aur RJ; Dahl GV; Pratt CB; Wood A; Avery TL
Cancer; 1980 Mar; 45(6):1284-8. PubMed ID: 7357520
[TBL] [Abstract][Full Text] [Related]
8. Etoposide and teniposide in the treatment of acute leukemia.
Björkholm M
Med Oncol Tumor Pharmacother; 1990; 7(1):3-10. PubMed ID: 2187120
[TBL] [Abstract][Full Text] [Related]
9. VM-26 and cytarabine combination chemotherapy in refractory or relapsed adult acute lymphoblastic leukemia.
Carella AM; Santini G; Martinengo M; Giordano D; Nati S; Congiu A; Risso M; Vimercati R; Cerri R; Rossi E
Haematologica; 1984; 69(6):747-51. PubMed ID: 6441752
[No Abstract] [Full Text] [Related]
10. [Treatment of acute refractory lymphoblastic leukemia in the adult with VM-26 and ARA-C].
Rafecas FJ; Sanz MA
Sangre (Barc); 1984; 29(6):1052-3. PubMed ID: 6598235
[No Abstract] [Full Text] [Related]
11. VM-26 and cytosine arabinoside combination chemotherapy for initial induction failures in childhood lymphocytic leukemia.
Rivera G; Dahl GV; Bowman WP; Avery TL; Wood A; Aur RJ
Cancer; 1980 Oct; 46(8):1727-30. PubMed ID: 6932995
[TBL] [Abstract][Full Text] [Related]
12. Severe hypertensive reactions to teniposide (VM-26) in infants with congenital leukemia.
Shimizu H; Frankel LS; Culbert SJ
Am J Pediatr Hematol Oncol; 1987; 9(3):239-41. PubMed ID: 3479027
[TBL] [Abstract][Full Text] [Related]
13. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
[TBL] [Abstract][Full Text] [Related]
14. Total-body irradiation and high-dose teniposide: a pilot study in bone marrow transplantation for patients with relapsed acute lymphoblastic leukemia.
Krance RA; Forman SJ; Blume KG
Cancer Treat Rep; 1987 Jun; 71(6):645-7. PubMed ID: 3555790
[TBL] [Abstract][Full Text] [Related]
15. High-dose Ara-C plus VM-26 in adult acute lymphoblastic leukemia.
Larson RA; Gaynor ER; Shepard KV; Daly KM
Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1261-3. PubMed ID: 3865776
[No Abstract] [Full Text] [Related]
16. Clinical trials of teniposide (VM-26) in childhood acute lymphocytic leukemia.
Rivera GK; Evans WE
Semin Oncol; 1992 Apr; 19(2 Suppl 6):51-8. PubMed ID: 1411639
[TBL] [Abstract][Full Text] [Related]
17. Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine.
Kamen BA; Casper J; Lauer S; Camitta BM; Holcenberg JS
Cancer Treat Rep; 1986 Jul; 70(7):935-6. PubMed ID: 3459577
[No Abstract] [Full Text] [Related]
18. Teniposide in lymphomas and leukemias.
Sonneveld P
Semin Oncol; 1992 Apr; 19(2 Suppl 6):59-64. PubMed ID: 1411640
[TBL] [Abstract][Full Text] [Related]
19. Teniposide is not effective in chronic lymphocytic leukemia.
Zagonel V; Tirelli U; Veronesi A; Galligioni E; Tumolo S; Roncadin M; Carbone A; Grigoletto E
Blut; 1986 Jan; 52(1):59-61. PubMed ID: 3632912
[TBL] [Abstract][Full Text] [Related]
20. VM26 therapy in children with drug-refractory lymphocytic leukemia.
Rivera G; Dahl GV; Murphy SB; Bowman WP; Aur RJ; Avery TL; Simone JV
Cancer Chemother Pharmacol; 1982; 7(2-3):169-72. PubMed ID: 7083458
[No Abstract] [Full Text] [Related]
[Next] [New Search]
